138 related articles for article (PubMed ID: 2960276)
21. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
[TBL] [Abstract][Full Text] [Related]
22. Monocyte-independent interleukin-2 production and proliferation of human T cells in response to murine hybridomas expressing the OKT3 monoclonal antibody: interleukin-1 is not required for T-cell proliferation.
Itoh K; Balch CM; Platsoucas CD
Cell Immunol; 1988 Aug; 115(1):36-56. PubMed ID: 2969776
[TBL] [Abstract][Full Text] [Related]
23. Correction of an in vitro immunoregulatory defect in atopic subjects by the immunostimulating drug fanetizole mesylate (CP-48,810).
Rocklin RE; Hemady Z; Matloff S; Kiselis I; Lima M
Int J Immunopharmacol; 1984; 6(1):1-8. PubMed ID: 6233230
[TBL] [Abstract][Full Text] [Related]
24. T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis.
Akdis CA; Akdis M; Simon D; Dibbert B; Weber M; Gratzl S; Kreyden O; Disch R; Wüthrich B; Blaser K; Simon HU
J Invest Dermatol; 1999 Oct; 113(4):628-34. PubMed ID: 10504452
[TBL] [Abstract][Full Text] [Related]
25. Quantitative analysis of T-lymphocyte subsets in atopic eczema, using monoclonal antibodies and flow cytofluorimetry.
Zachary CB; MacDonald DM
Br J Dermatol; 1983 Apr; 108(4):411-22. PubMed ID: 6220732
[TBL] [Abstract][Full Text] [Related]
26. Staphylococcal α-toxin induces a higher T cell proliferation and interleukin-31 in atopic dermatitis.
Niebuhr M; Mamerow D; Heratizadeh A; Satzger I; Werfel T
Int Arch Allergy Immunol; 2011; 156(4):412-5. PubMed ID: 21832830
[TBL] [Abstract][Full Text] [Related]
27. Relative impact of CD4+CD25+ regulatory T cells and tacrolimus on inhibition of T-cell proliferation in patients with atopic dermatitis.
Vukmanovic-Stejic M; McQuaid A; Birch KE; Reed JR; Macgregor C; Rustin MH; Akbar AN
Br J Dermatol; 2005 Oct; 153(4):750-7. PubMed ID: 16181456
[TBL] [Abstract][Full Text] [Related]
28. [Pathogenesis of atopic diseases].
Ricci M; Romagnani S; Maggi E; Del Prete G
Recenti Prog Med; 1984 May; 75(5):496-513. PubMed ID: 6237398
[No Abstract] [Full Text] [Related]
29. Deficient concanavalin-A-induced suppressor-cell activity in patients with bronchial asthma, allergic rhinitis and atopic dermatitis.
Hwang KC; Fikrig SM; Friedman HM; Gupta S
Clin Allergy; 1985 Jan; 15(1):67-72. PubMed ID: 3156692
[TBL] [Abstract][Full Text] [Related]
30. Altered production of immuno-modulating cytokines in patients with atopic dermatitis.
Kapp A; Kirnbauer R; Luger TA; Schöpf E
Acta Derm Venereol Suppl (Stockh); 1989; 144():97-9. PubMed ID: 2800914
[TBL] [Abstract][Full Text] [Related]
31. Staphylococcus aureus from atopic dermatitis skin alters cytokine production triggered by monocyte-derived Langerhans cell.
Iwamoto K; Moriwaki M; Niitsu Y; Saino M; Takahagi S; Hisatsune J; Sugai M; Hide M
J Dermatol Sci; 2017 Dec; 88(3):271-279. PubMed ID: 28822698
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-1 release from peripheral blood monocytes and soluble interleukin-2 and CD8 receptors in serum from patients with atopic dermatitis.
Thestrup-Pedersen K; Larsen CS; Kristensen M; Zachariae C
Acta Derm Venereol; 1990; 70(5):395-9. PubMed ID: 1980972
[TBL] [Abstract][Full Text] [Related]
33. Modifying the biological response in acute myeloid leukemia. II. Effect of BCG and leukemic cells on lymphocyte response to mitogens, and on helper and suppressor activity.
Arends-Merino A; Giscombe R; Ogier C; Reizenstein P; Sjörgen AM; Wasserman J
Cancer Immunol Immunother; 1982; 14(1):32-5. PubMed ID: 6218871
[TBL] [Abstract][Full Text] [Related]
34. An in vitro study of depressed cell-mediated immunity and of T and B lymphocytes in atopic dermatitis.
Hovmark A
Acta Derm Venereol; 1977; 57(3):237-42. PubMed ID: 71829
[TBL] [Abstract][Full Text] [Related]
35. Deficient translocation of c-Rel is associated with impaired Th1 cytokine production in T cells from atopic dermatitis patients.
Dieckhoff K; Graf P; Beinhauer B; Schwaerzler C; Carballido JM; Neumann C; Zachmann K; Jung T
Exp Dermatol; 2005 Jan; 14(1):17-25. PubMed ID: 15660915
[TBL] [Abstract][Full Text] [Related]
36. Modulation of CD3-dependent lymphocyte proliferation by extracellular matrix proteins in atopic dermatitis.
Glinski W; Stepien-Sopniewska B; Korczak-Kowalska G; Glinska-Ferenz M; Gorski A
Acta Derm Venereol; 1995 Sep; 75(5):353-6. PubMed ID: 8615050
[TBL] [Abstract][Full Text] [Related]
37. [Determination of circulating lymphocyte subpopulations in atopic dermatitis using monoclonal antibodies].
De Maubeuge J; Delespesse G; Achten G; Servais G; De Vetter L; Gaillaert N
Dermatologica; 1984; 169(1):6-11. PubMed ID: 6236116
[TBL] [Abstract][Full Text] [Related]
38. Immune regulation by platelet-activating factor. I. Induction of suppressor cell activity in human monocytes and CD8+ T cells and of helper cell activity in CD4+ T cells.
Rola-Pleszczynski M; Pouliot C; Turcotte S; Pignol B; Braquet P; Bouvrette L
J Immunol; 1988 May; 140(10):3547-52. PubMed ID: 2834440
[TBL] [Abstract][Full Text] [Related]
39. Abnormal suppressor cell function in atopic dermatitis.
Rola-Pleszczynski M; Blanchard R
J Invest Dermatol; 1981 Apr; 76(4):279-83. PubMed ID: 6451654
[TBL] [Abstract][Full Text] [Related]
40. Different expression of cytokine and membrane molecules by circulating lymphocytes on acute mental stress in patients with atopic dermatitis in comparison with healthy controls.
Schmid-Ott G; Jaeger B; Meyer S; Stephan E; Kapp A; Werfel T
J Allergy Clin Immunol; 2001 Sep; 108(3):455-62. PubMed ID: 11544468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
